Literature DB >> 25393804

Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias.

Deepesh P Lad1, Subhash Varma1, Neelam Varma2, Man Updesh Singh Sachdeva2, Parveen Bose2, Pankaj Malhotra1.   

Abstract

The reasons for progression and autoimmune cytopenias (AIC) in chronic lymphocytic leukemia (CLL) are not entirely clear, with previous studies suggesting a role for regulatory T-cells (Treg). In this study we prospectively studied Treg (CD3+CD4+CD25highCD127low), interleukin-10 (IL-10) producing Treg and T-helper 17 (Th17) (CD3+CD4+IL-17+) cells in 40 treatment-naive patients with CLL. The percentage of Th17 and not Treg cells was significantly higher in the AIC cohort than in those without AIC (p<0.0001). The Treg:Th17 ratio was skewed in favor of Th17 in the AIC cohort (p=0.02). Th17 cells are responsible for AIC of CLL. Analysis of lymph-node aspirates showed that the percentage of Treg and IL-10 expression in Treg and not Th17 was significantly higher than in peripheral blood (p<0.01). Treg cells play a major role in the microenvironment where disease progression occurs. This shows the importance of maintaining the Treg:Th17 equilibrium, for imbalance leads to CLL progression or AIC.

Entities:  

Keywords:  Autoimmune cytopenia; T-helper 17; chronic lymphocytic leukemia; regulatory T-cells

Mesh:

Substances:

Year:  2015        PMID: 25393804     DOI: 10.3109/10428194.2014.986479

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  17 in total

Review 1.  A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

Authors:  Mazie Tsang; Sameer A Parikh
Journal:  Curr Hematol Malig Rep       Date:  2017-02       Impact factor: 3.952

2.  Ibrutinib Therapy Increases T Cell Repertoire Diversity in Patients with Chronic Lymphocytic Leukemia.

Authors:  Qingsong Yin; Mariela Sivina; Harlan Robins; Erik Yusko; Marissa Vignali; Susan O'Brien; Michael J Keating; Alessandra Ferrajoli; Zeev Estrov; Nitin Jain; William G Wierda; Jan A Burger
Journal:  J Immunol       Date:  2017-01-11       Impact factor: 5.422

3.  Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

Authors:  Paul J Hampel; Melissa C Larson; Brian Kabat; Timothy G Call; Wei Ding; Saad S Kenderian; Deborah Bowen; Justin Boysen; Susan M Schwager; Jose F Leis; Asher A Chanan-Khan; Eli Muchtar; Curtis A Hanson; Susan L Slager; Neil E Kay; Kari G Chaffee; Tait D Shanafelt; Sameer A Parikh
Journal:  Br J Haematol       Date:  2018-08-16       Impact factor: 6.998

Review 4.  Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.

Authors:  Noelia Purroy; Catherine J Wu
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 5.  Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia.

Authors:  Kamira Maharaj; Eva Sahakian; Javier Pinilla-Ibarz
Journal:  Blood Adv       Date:  2017-09-26

6.  Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin's lymphoma.

Authors:  Iwona Hus; Agnieszka Bojarska-Junak; Marzena Kamińska; Aneta Dobrzyńska-Rutkowska; Karolina Szatan; Agnieszka Szymczyk; Bożena Kukiełka-Budny; Dariusz Szczepanek; Jacek Roliński
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

7.  Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.

Authors:  Carsten U Niemann; Sarah E M Herman; Irina Maric; Julio Gomez-Rodriguez; Angelique Biancotto; Betty Y Chang; Sabrina Martyr; Maryalice Stetler-Stevenson; Constance M Yuan; Katherine R Calvo; Raul C Braylan; Janet Valdez; Yuh Shan Lee; Deanna H Wong; Jade Jones; Clare Sun; Gerald E Marti; Mohammed Z H Farooqui; Adrian Wiestner
Journal:  Clin Cancer Res       Date:  2015-12-09       Impact factor: 12.531

8.  Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.

Authors:  Agata A Filip; Anna Grenda; Sylwia Popek; Dorota Koczkodaj; Małgorzata Michalak-Wojnowska; Michał Budzyński; Ewa Wąsik-Szczepanek; Szymon Zmorzyński; Agnieszka Karczmarczyk; Krzysztof Giannopoulos
Journal:  Ann Hematol       Date:  2016-10-12       Impact factor: 3.673

Review 9.  Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk.

Authors:  Martijn Ha van Attekum; Eric Eldering; Arnon P Kater
Journal:  Haematologica       Date:  2017-08-03       Impact factor: 9.941

10.  Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation.

Authors:  Sung Woong Jang; Soo Seok Hwang; Hyeong Su Kim; Keoung Oh Lee; Min Kyung Kim; Wonyong Lee; Kiwan Kim; Gap Ryol Lee
Journal:  Exp Mol Med       Date:  2017-09-08       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.